0TDF.LSE Roche Holding AG

Healthcare Drug Manufacturers - General London Exchange
- USD
Market cap
-
P/E
29.1x
P/B
-
ROE
-
Dividend yield
1.99%
Fundamental score
-

Is 0TDF.LSE undervalued?

Graham number

The Graham number of Roche Holding AG cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Roche Holding AG fundamental analysis

No fundamental analysis for Roche Holding AG yet.

Roche Holding AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various dise…

Full company profile